This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Gerald Sonnenfeld: Innovator in Transplant Medicine
Introduction
Gerald Sonnenfeld is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of transplant medicine, particularly in the prevention and treatment of microbial infections in transplant patients. His innovative approach has the potential to improve patient outcomes and enhance the quality of life for those undergoing transplantation.
Latest Patents
Gerald Sonnenfeld holds a patent for the invention titled "Control of microbial infections in transplant patients." This invention focuses on the use of lymphokines, specifically gamma interferon (IFN-.gamma.), for the prophylaxis and treatment of microbial infections in transplant recipients. Notably, this method aims to prevent infections without increasing the incidence of graft rejections, which is a critical concern in transplant medicine. He has 1 patent to his name.
Career Highlights
Sonnenfeld's career is marked by his work at Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His research and development efforts have contributed to advancements in the treatment of various medical conditions, particularly in the realm of transplantation.
Collaborations
Throughout his career, Gerald Sonnenfeld has collaborated with esteemed colleagues, including Jon B Klein and Christine W Czarniecki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical research.
Conclusion
Gerald Sonnenfeld's contributions to transplant medicine through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field and offers hope for better treatment options for transplant patients.